Financial Gravity Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Financial Gravity Asset Management's EW Position: Q1 2026 in Review
Financial Gravity Asset Management opened a new position in Edwards Lifesciences (EW) in Q1 2026: 12 shares worth $961. The stake represents ﹤0.01% of the portfolio and ranks #759 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in EW as recently as Q1 2025.
Financial Gravity Asset Management first reported a position in EW in Q1 2018 and has held it in 22 quarters since. The position peaked at $233K in Q4 2019. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Financial Gravity Asset Management held 12 shares of Edwards Lifesciences worth $961 as of Q1 2026.
- Edwards Lifesciences was a new Financial Gravity Asset Management position in Q1 2026.
- Edwards Lifesciences made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #759 holding.
- Financial Gravity Asset Management first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 22 quarters since.
- Financial Gravity Asset Management's Edwards Lifesciences position peaked at $233K in Q4 2019.
- 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.